Sildenafil protects against 3-nitropropionic acid neurotoxicity through the modulation of calpain, CREB, and BDNF. 2010

Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
Department of Pharmacology, School of Medicine, University of Navarra, Pamplona, Spain.

In this study we tested whether phosphodiesterase 5 (PDE5) inhibitors, sildenafil and vardenafil, would afford protection against 3-nitropropionic acid (3NP), which produces striatal lesions that closely mimic some of the neuropathological features of Huntington's Disease (HD). The neurotoxin was given over 5 days by constant systemic infusion using osmotic minipumps. Animals treated with PDE5 inhibitors (sildenafil or vardenafil) showed improved neurologic scores, reduced the loss of striatal DARPP-32 protein levels and lesion volumes, and decreased calpain activation produced by 3NP. This protective effect was independent of changes in 3NP-induced succinate dehydrogenase inhibition. Furthermore, striatal p-CREB levels along with the expression of BDNF were significantly increased in sildenafil-treated rats. In summary, PDE5 inhibitors protected against 3NP-induced striatal degeneration by reducing calpain activation and by promoting survival pathways. These data encourage further evaluation of PDE5 inhibitors in transgenic mouse models of HD.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009498 Neurotoxins Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. Alpha-Neurotoxin,Excitatory Neurotoxin,Excitotoxins,Myotoxin,Myotoxins,Neurotoxin,Alpha-Neurotoxins,Excitatory Neurotoxins,Excitotoxin,Alpha Neurotoxin,Alpha Neurotoxins,Neurotoxin, Excitatory,Neurotoxins, Excitatory
D009574 Nitro Compounds Compounds having the nitro group, -NO2, attached to carbon. When attached to nitrogen they are nitramines and attached to oxygen they are NITRATES. Nitrated Compounds
D010726 Phosphodiesterase Inhibitors Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. Phosphodiesterase Antagonists,Phosphodiesterase Inhibitor,Phosphoric Diester Hydrolase Inhibitors,Antiphosphodiesterases,Inhibitor, Phosphodiesterase
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011422 Propionates Derivatives of propionic acid. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxyethane structure. Propanoate,Propanoic Acid,Propionate,Propanoates,Propanoic Acid Derivatives,Propanoic Acids,Propionic Acid Derivatives,Propionic Acids,Acid, Propanoic,Acids, Propanoic,Acids, Propionic,Derivatives, Propanoic Acid,Derivatives, Propionic Acid
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew

Related Publications

Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
January 2010, Neurochemistry international,
Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
August 2005, Journal of neurochemistry,
Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
August 2000, Neuroreport,
Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
June 2021, Toxicology mechanisms and methods,
Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
March 2021, The Journal of pharmacy and pharmacology,
Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
November 2009, Life sciences,
Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
October 2005, Neuropharmacology,
Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
January 2022, Current research in pharmacology and drug discovery,
Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
August 2018, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Elena Puerta, and Isabel Hervias, and Lucía Barros-Miñones, and Joaquin Jordan, and Ana Ricobaraza, and Mar Cuadrado-Tejedor, and Ana García-Osta, and Norberto Aguirre
July 2009, Biochemical and biophysical research communications,
Copied contents to your clipboard!